Skip to main content
OpenTrials

Clinical trial condition

Chronic Myelomonocytic Leukemia

Explore clinical trials studying Chronic Myelomonocytic Leukemia. Study availability and eligibility vary by location and protocol.

191 public trials 39 recruiting studies
Refine in advanced search Browse all conditions

Chronic Myelomonocytic Leukemia trial results

Completed

IDH2-Post-Allo-Trial for Patients with IDH2-mut Myeloid Neoplasms After Allo-SCT

NCT04522895

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +16 more
Locations
  • University Hospital Duesseldorf Dept. of Hematology, Oncology and Clinical Immunology Düsseldorf, North Rhine-Westphalia, Germany
  • Uniklinik RWTH Aachen Klinik für Hämatologie, Onkologie, Hämostaseologie und Stammzelltransplantation (Med. Klinik IV) Aachen, Germany
  • Universitätsklinikum Köln Klinik I für Innere Medizin Cologne, Germany
  • Universitätsklinikum Carl Gustav Carus Medizinische Klinik und Poliklinik I Dresden, Germany
View Trial Details
Completed

Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML

NCT03306264

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Pinnacle Research Group Anniston, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • Compassionate Cancer Care Research Group Fountain Valley, California, United States
View all 84 locations
View Trial Details
Completed

Effect of Food on Blood Levels of ASTX727

NCT03813186

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Roswell Park Buffalo, New York, United States
  • Gabrail Cancer Center Canton, Ohio, United States
  • Vanderbilt Nashville, Tennessee, United States
  • Mays Cancer Center UT Health San Antonio MD Anderson Cancer Center San Antonio, Texas, United States
View Trial Details
Completed

Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486

NCT03493646

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • Calvary Mater Newcastle Newcastle, New South Wales, Australia
  • Nepean Hospital Penrith, New South Wales, Australia
  • Prince of Wales Hospital Sydney, New South Wales, Australia
  • Royal North Shore Hospital Sydney, New South Wales, Australia
View Trial Details
Completed

Registry on Hypomethylating Agents in Myeloid Neoplasms

NCT01595295

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +14 more
Locations
  • LKH Feldkirch, Innere Med. II, Interne E Feldkirch, Austria
  • LKH Fürstenfeld Fürstenfeld, Austria
  • UK Graz: Universitätsklinik für Innere Medizin; Klinische Abteilung für Hämatologie Graz, Austria
  • Universitätsklinik für Innere Medizin V Innsbruck, Austria
View all 20 locations
View Trial Details
Completed

Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant

NCT01812252

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +15 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • Kaiser Permanente Washington Seattle, Washington, United States
View Trial Details
Completed

A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients

NCT02367456

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +15 more
Locations
  • University of Alabama at Birmingham the Kirklin Clinic Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Smilow Cancer Center at Yale New Haven Hospital New Haven, Connecticut, United States
View all 33 locations
View Trial Details
Completed

Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML

NCT04842604

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +15 more
Locations
  • Landeskrankenhaus Salzburg, Universitatsklinik fur Innere Medizin III der PMU Salzburg, Austria
  • Uniklinikum Salzburg, Landeskrankenhaus Salzburg Salzburg, Austria
  • Health Sciences Centre Winnipeg, Manitoba, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View all 18 locations
View Trial Details

Related conditions